Authors:
ANDREYEV HJN
NORMAN AR
CUNNINGHAM D
OATES JR
CLARKE PA
Citation: Hjn. Andreyev et al., KIRSTEN RAS MUTATIONS IN PATIENTS WITH COLORECTAL-CANCER - THE MULTICENTER RASCAL STUDY, Journal of the National Cancer Institute, 90(9), 1998, pp. 675-684
Authors:
ANDREYEV HJN
NORMAN AR
OATES J
CUNNINGHAM D
Citation: Hjn. Andreyev et al., WHY DO PATIENTS WITH WEIGHT-LOSS HAVE A WORSE OUTCOME WHEN UNDERGOINGCHEMOTHERAPY FOR GASTROINTESTINAL MALIGNANCIES, European journal of cancer, 34(4), 1998, pp. 503-509
Authors:
ANDREYEV HJN
NORMAN AR
OATES J
CUNNINGHAM D
Citation: Hjn. Andreyev et al., WHY DO PATIENTS WITH WEIGHT-LOSS HAVE A WORSE OUTCOME WHEN UNDERGOINGCHEMOTHERAPY FOR GASTROINTESTINAL MALIGNANCIES, Gut, 40, 1997, pp. 73-73
Authors:
ANDREYEV HJN
ROSS PJ
CUNNINGHAM D
CLARKE PA
Citation: Hjn. Andreyev et al., EFFECTIVE TARGETING OF COLORECTAL-CANCER KIRSTEN RAS POINT MUTATIONS WITH ANTISENSE THERAPY IN-VITRO, Gut, 40, 1997, pp. 178-178
Authors:
ANDREYEV HJN
NORMAN AR
CUNNINGHAM D
OATES J
CLARKE PA
Citation: Hjn. Andreyev et al., KIRSTEN RAS MUTATIONS IN 2,667 PATIENTS WITH COLORECTAL-CANCER - RESULTS OF THE RASCAL (RAS COLLABORATIVE) PROJECT, Gut, 40, 1997, pp. 193-193
Authors:
ANDREYEV HJN
NORMAN AR
OATES J
CUNNINGHAM D
Citation: Hjn. Andreyev et al., WHY DO PATIENTS WITH WEIGHT-LOSS HAVE A WORSE OUTCOME WHEN UNDERGOINGCHEMOTHERAPY FOR GASTROINTESTINAL MALIGNANCIES, Gastroenterology, 112(4), 1997, pp. 532-532
Authors:
ANDREYEV HJN
ROSS PJ
CUNNINGHAM D
CLARKE PA
Citation: Hjn. Andreyev et al., EFFECTIVE TARGETING OF COLORECTAL-CANCER KIRSTEN RAS POINT MUTATIONS WITH ANTISENSE THERAPY IN-VITRO, Gastroenterology, 112(4), 1997, pp. 532-532
Authors:
ANDREYEV HJN
NORMAN AR
CUNNINGHAM D
OATES J
CLARKE PA
Citation: Hjn. Andreyev et al., KIRSTEN RAS MUTATIONS IN 2,667 PATIENTS WITH COLORECTAL-CANCER - RESULTS OF THE RASCAL (RAS COLLABORATIVE) PROJECT, Gastroenterology, 112(4), 1997, pp. 532-532
Authors:
SCHNEIDER HJ
SAMPSON SA
CUNNINGHAM D
NORMAN AR
ANDREYEV HJN
TILSED JVT
CLARKE PA
Citation: Hj. Schneider et al., BCL-2 EXPRESSION AND RESPONSE TO CHEMOTHERAPY IN COLORECTAL ADENOCARCINOMAS, British Journal of Cancer, 75(3), 1997, pp. 427-431
Authors:
ANDREYEV HJN
KAMM MA
FORBES A
NICHOLLS RJ
Citation: Hjn. Andreyev et al., JOINT SYMPTOMS AFTER RESTORATIVE PROCTOCOLECTOMY IN ULCERATIVE-COLITIS AND FAMILIAL POLYPOSIS-COLI, Journal of clinical gastroenterology, 23(1), 1996, pp. 35-39
Authors:
ANDREYEV HJN
TILSED JVT
CUNNINGHAM D
SAMPSON SA
NORMAN AR
SCHNEIDER HJ
CLARKE P
Citation: Hjn. Andreyev et al., MUTATIONS IN CODON-12 AND CODON-13 OF THE KIRSTEN-RAS GENE ARE NOT RELATED TO RELAPSE IN PATIENTS WITH EARLY COLORECTAL CANCERS, Gastroenterology, 110(4), 1996, pp. 484-484
Authors:
CLARKE PA
SCHNEIDER HJ
CUNNINGHAM D
NORMAN AR
SAMPSON SA
TILSED JVT
ANDREYEV HJN
Citation: Pa. Clarke et al., BCL-2 EXPRESSION DOES NOT INFLUENCE RESPONSE TO CHEMOTHERAPY IN COLORECTAL-CANCER, Gastroenterology, 110(4), 1996, pp. 504-504
Authors:
ANDREYEV HJN
NORMAN AR
CUNNINGHAM D
PADHANI AR
HILL AS
ROSS PJ
WEBB A
Citation: Hjn. Andreyev et al., SQUAMOUS ESOPHAGEAL CANCER CAN BE DOWNSTAGED USING PROTRACTED VENOUS INFUSION OF 5-FLUOROURACIL WITH EPIRUBICIN AND CISPLATIN (ECF), European journal of cancer, 31A(13-14), 1995, pp. 2209-2214
Authors:
ANDREYEV HJN
SCOTTMACKIE P
CUNNINGHAM D
NICOLSON V
NORMAN AR
BADVE SS
IVESON A
NICOLSON MC
Citation: Hjn. Andreyev et al., PHASE-II STUDY OF CONTINUOUS-INFUSION FLUOROURACIL AND INTERFERON ALFA-2B IN THE PALLIATION OF MALIGNANT NEUROENDOCRINE TUMORS, Journal of clinical oncology, 13(6), 1995, pp. 1486-1492
Authors:
ANDREYEV HJN
KAMM MA
NICHOLLS RJ
FORBES A
Citation: Hjn. Andreyev et al., ARTHROPATHY OF INFLAMMATORY BOWEL-DISEASE AND THE EFFECT OF RESTORATIVE PROCTOCOLECTOMY, Gastroenterology, 108(4), 1995, pp. 770-770
Authors:
ANDREYEV HJN
OWEN RA
THOMAS PA
WRIGHT PL
FORBES A
Citation: Hjn. Andreyev et al., ACID-SECRETION FROM A MECKELS-DIVERTICULUM - THE UNSUSPECTED MIMIC OFCROHNS-DISEASE, The American journal of gastroenterology, 89(9), 1994, pp. 1552-1554
Citation: Hjn. Andreyev et al., TESTICULAR NONSEMINOMA WITH HIGH SERUM HUMAN CHORIONIC-GONADOTROPIN -THE TROPHOBLASTIC TERATOMA SYNDROME, Diagnostic oncology, 3(2), 1993, pp. 67-71